Category: Side Effect: Kidney Injury (chronic kidney disease, acute renal failure)
-
April 2009 FDA “Patient Safety News” Videos For Doctors Online
Covers Bowel Cleansing Agents Visicol and OsmoPrep, As Well As Methadone Overdoses, Ethex Generic Drug Recall, And Medication Errors (Posted by Tom Lamb at DrugInjuryWatch.com) The FDA's Patient Safety News (PSN) is a series of…
-
Warnings About Byetta Associated With Risk Of Severe Pancreatitis And Renal Failure
March 2009 Drug Safety Update Newsletter (UK) Raises Emerging Safety Issue Of Kidney-Related Side Effects From Byetta Use (Posted by Tom Lamb at DrugInjuryWatch.com) _____________________________________________________________________________ UPDATE: "Diabetes Drug Byetta Linked To Kidney Problems And Cases…
-
Prescription Oral Sodium Phosphate (OSP) Products Visicol And OsmoPrep Get Black-Box Warning
Related Recall Of Over-The-Counter OSP Fleet Phospho-Soda, Which Is Subject Of Product Liability Lawsuits (Posted by Tom Lamb at DrugInjuryWatch.com) On December 11, 2008 the FDA issued by email a MedWatch Safety Alert which was titled…
-
Dr. Dennis Mangano Says On 60 Minutes In February 2008 That Trasylol Should Have Been Recalled As Early As January 2006
Delay By Bayer And FDA Until November 2007, When Trasylol Sales Were "Suspended", Caused 22,000 Excess Deaths Per CBS Report (Posted by Tom Lamb at DrugInjuryWatch.com) According to interviews broadcast by CBS Television’s 60…
-
Trasylol Sales In U.S. And Canada Suspended Temporarily By Bayer In Early November 2007
Market Withdrawal Or Recall Of Trasylol Seems Possible As Bayer Waits For Final Data From Halted BART Study (Posted by Tom Lamb at DrugInjuryWatch.com) On November 5, 2007 the FDA announced and Health Canada…
-
FDA Updates Exjade Adverse Drug Reaction Numbers In Its First Drug-Safety Newsletter
FDA Post-Marketing Safety Review Adds Liver Problems To Previous Reports Of Kidney Failure Associated With Exjade (Posted by Tom Lamb at DrugInjuryWatch.com) In the first edition of FDA Drug Safety Newsletter (Volume 1, Number…
-
Natrecor Is Associated With Increased Risk Of Acute Renal Failure And Death
Questions About Safety Of Natrecor Continue, With No Apparent Resolution Any Time Soon (Posted by Tom Lamb at DrugInjuryWatch.com) As reported previously, in June 2007 Scios, Inc. announced it had started enrolling patients in…
-
Safety Of Trasylol Will Be Reviewed By FDA Advisory Panel In September 2007
Will Consider Data Suggesting Trasylol Can Cause Kidney Damage, Heart Failure, and Death (Posted by Tom Lamb at DrugInjuryWatch.com) An August 22, 2007 article, "FDA panel will review Trasylol safety", published in the The…
-
Long-Awaited Natrecor Trial Starts To Enroll Patients In June 2007
Scios Inc. Finally Going To Assess Benefit / Risk Profile Of Natrecor In Large Trial Of Patients With Acutely Decompensated Heart Failure On June 8, 2007 Scios, Inc. let the public know that it…
-
Natrecor Safety Controversy Considered In Two May 2007 Medical Journal Articles
Is Natrecor An Example Of Why Dr. Steven Nissen Thinks That The FDA Is Dysfunctional And In Need Of Reform? (Posted by Tom Lamb at DrugInjuryWatch.com) Natrecor (nesiritide) is approved for the treatment of…